{"entity":{"type":"insider","cik":"0001288528","url":"/insider/0001288528","json_url":"/insider/0001288528.json","name":"MORGANS DAVID J JR","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":110,"n_filings":27,"first":"2005-11-04","last":"2009-10-02","span_basis":"filed_date"},"name_variants":[{"name":"MORGANS DAVID J JR","source":"filing","n_filings":27,"first_seen":"2005-11-04","last_seen":"2009-10-02"}],"transactions":[{"id":5686906,"accession":"0001061983-09-000044","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001061983-09-000044","line_url":"/filing/0001061983-09-000044#line-6","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4400.0,"shares_display":"4,400","price_per_share":5.19,"price_display":"5.19","price_state":"stated","total_value":22836.0,"total_display":"22,836.00","shares_owned_after":44334.0,"shares_owned_after_display":"44,334","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-01","filed_date":"2009-10-02","scope":"insider"},{"id":5686905,"accession":"0001061983-09-000044","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001061983-09-000044","line_url":"/filing/0001061983-09-000044#line-5","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400.0,"shares_display":"1,400","price_per_share":5.22,"price_display":"5.22","price_state":"stated","total_value":7308.0,"total_display":"7,308.00","shares_owned_after":42400.0,"shares_owned_after_display":"42,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-01","filed_date":"2009-10-02","scope":"insider"},{"id":5686904,"accession":"0001061983-09-000044","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001061983-09-000044","line_url":"/filing/0001061983-09-000044#line-4","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":766.0,"shares_display":"766","price_per_share":5.17,"price_display":"5.17","price_state":"stated","total_value":3960.22,"total_display":"3,960.22","shares_owned_after":48734.0,"shares_owned_after_display":"48,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-01","filed_date":"2009-10-02","scope":"insider"},{"id":5686903,"accession":"0001061983-09-000044","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001061983-09-000044","line_url":"/filing/0001061983-09-000044#line-3","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":534.0,"shares_display":"534","price_per_share":5.2,"price_display":"5.20","price_state":"stated","total_value":2776.8,"total_display":"2,776.80","shares_owned_after":43800.0,"shares_owned_after_display":"43,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-01","filed_date":"2009-10-02","scope":"insider"},{"id":5686902,"accession":"0001061983-09-000044","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001061983-09-000044","line_url":"/filing/0001061983-09-000044#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":5.24,"price_display":"5.24","price_state":"stated","total_value":1048.0,"total_display":"1,048.00","shares_owned_after":42000.0,"shares_owned_after_display":"42,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-01","filed_date":"2009-10-02","scope":"insider"},{"id":5686901,"accession":"0001061983-09-000044","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001061983-09-000044","line_url":"/filing/0001061983-09-000044#line-1","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":5.23,"price_display":"5.23","price_state":"stated","total_value":1046.0,"total_display":"1,046.00","shares_owned_after":42200.0,"shares_owned_after_display":"42,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-01","filed_date":"2009-10-02","scope":"insider"},{"id":5776485,"accession":"0001061983-09-000043","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001061983-09-000043","line_url":"/filing/0001061983-09-000043#line-1","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":5.5,"price_display":"5.50","price_state":"stated","total_value":13750.0,"total_display":"13,750.00","shares_owned_after":49500.0,"shares_owned_after_display":"49,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-28","filed_date":"2009-09-29","scope":"insider"},{"id":5735197,"accession":"0001061983-09-000041","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001061983-09-000041","line_url":"/filing/0001061983-09-000041#line-11","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":12500.0,"total_display":"12,500.00","shares_owned_after":52000.0,"shares_owned_after_display":"52,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-21","filed_date":"2009-09-22","scope":"insider"},{"id":5735196,"accession":"0001061983-09-000041","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001061983-09-000041","line_url":"/filing/0001061983-09-000041#line-10","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400.0,"shares_display":"1,400","price_per_share":4.7301,"price_display":"4.73","price_state":"stated","total_value":6622.14,"total_display":"6,622.14","shares_owned_after":57800.0,"shares_owned_after_display":"57,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-21","filed_date":"2009-09-22","scope":"insider"},{"id":5735195,"accession":"0001061983-09-000041","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001061983-09-000041","line_url":"/filing/0001061983-09-000041#line-9","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":4.7601,"price_display":"4.76","price_state":"stated","total_value":5712.12,"total_display":"5,712.12","shares_owned_after":55400.0,"shares_owned_after_display":"55,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-21","filed_date":"2009-09-22","scope":"insider"},{"id":5735194,"accession":"0001061983-09-000041","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001061983-09-000041","line_url":"/filing/0001061983-09-000041#line-8","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":4.7501,"price_display":"4.75","price_state":"stated","total_value":2375.05,"total_display":"2,375.05","shares_owned_after":56600.0,"shares_owned_after_display":"56,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-21","filed_date":"2009-09-22","scope":"insider"},{"id":5735193,"accession":"0001061983-09-000041","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001061983-09-000041","line_url":"/filing/0001061983-09-000041#line-7","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":4.7701,"price_display":"4.77","price_state":"stated","total_value":1908.04,"total_display":"1,908.04","shares_owned_after":54600.0,"shares_owned_after_display":"54,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-21","filed_date":"2009-09-22","scope":"insider"},{"id":5735192,"accession":"0001061983-09-000041","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001061983-09-000041","line_url":"/filing/0001061983-09-000041#line-6","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":4.75,"price_display":"4.75","price_state":"stated","total_value":1900.0,"total_display":"1,900.00","shares_owned_after":57100.0,"shares_owned_after_display":"57,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-21","filed_date":"2009-09-22","scope":"insider"},{"id":5735191,"accession":"0001061983-09-000041","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001061983-09-000041","line_url":"/filing/0001061983-09-000041#line-5","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":4.762,"price_display":"4.76","price_state":"stated","total_value":1428.6,"total_display":"1,428.60","shares_owned_after":55100.0,"shares_owned_after_display":"55,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-21","filed_date":"2009-09-22","scope":"insider"},{"id":5735190,"accession":"0001061983-09-000041","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001061983-09-000041","line_url":"/filing/0001061983-09-000041#line-4","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":4.74,"price_display":"4.74","price_state":"stated","total_value":1422.0,"total_display":"1,422.00","shares_owned_after":57500.0,"shares_owned_after_display":"57,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-21","filed_date":"2009-09-22","scope":"insider"},{"id":5735189,"accession":"0001061983-09-000041","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001061983-09-000041","line_url":"/filing/0001061983-09-000041#line-3","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":4.6901,"price_display":"4.69","price_state":"stated","total_value":1407.03,"total_display":"1,407.03","shares_owned_after":59200.0,"shares_owned_after_display":"59,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-21","filed_date":"2009-09-22","scope":"insider"},{"id":5735188,"accession":"0001061983-09-000041","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001061983-09-000041","line_url":"/filing/0001061983-09-000041#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":4.7801,"price_display":"4.78","price_state":"stated","total_value":478.01,"total_display":"478.01","shares_owned_after":54500.0,"shares_owned_after_display":"54,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-21","filed_date":"2009-09-22","scope":"insider"},{"id":5735187,"accession":"0001061983-09-000041","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001061983-09-000041","line_url":"/filing/0001061983-09-000041#line-1","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":4.77,"price_display":"4.77","price_state":"stated","total_value":477.0,"total_display":"477.00","shares_owned_after":55000.0,"shares_owned_after_display":"55,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-21","filed_date":"2009-09-22","scope":"insider"},{"id":5686900,"accession":"0001061983-09-000015","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001061983-09-000015","line_url":"/filing/0001061983-09-000015#line-5","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3700.0,"shares_display":"3,700","price_per_share":1.54,"price_display":"1.54","price_state":"stated","total_value":5698.0,"total_display":"5,698.00","shares_owned_after":60600.0,"shares_owned_after_display":"60,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-03-02","filed_date":"2009-03-03","scope":"insider"},{"id":5686899,"accession":"0001061983-09-000015","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001061983-09-000015","line_url":"/filing/0001061983-09-000015#line-4","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":1.55,"price_display":"1.55","price_state":"stated","total_value":1395.0,"total_display":"1,395.00","shares_owned_after":59700.0,"shares_owned_after_display":"59,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-03-02","filed_date":"2009-03-03","scope":"insider"},{"id":5686898,"accession":"0001061983-09-000015","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001061983-09-000015","line_url":"/filing/0001061983-09-000015#line-3","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":1.52,"price_display":"1.52","price_state":"stated","total_value":304.0,"total_display":"304.00","shares_owned_after":64300.0,"shares_owned_after_display":"64,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-03-02","filed_date":"2009-03-03","scope":"insider"},{"id":5686897,"accession":"0001061983-09-000015","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001061983-09-000015","line_url":"/filing/0001061983-09-000015#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":1.61,"price_display":"1.61","price_state":"stated","total_value":161.0,"total_display":"161.00","shares_owned_after":59500.0,"shares_owned_after_display":"59,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-03-02","filed_date":"2009-03-03","scope":"insider"},{"id":5686896,"accession":"0001061983-09-000015","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001061983-09-000015","line_url":"/filing/0001061983-09-000015#line-1","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":1.58,"price_display":"1.58","price_state":"stated","total_value":158.0,"total_display":"158.00","shares_owned_after":59600.0,"shares_owned_after_display":"59,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-03-02","filed_date":"2009-03-03","scope":"insider"},{"id":5938574,"accession":"0001061983-09-000004","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001061983-09-000004","line_url":"/filing/0001061983-09-000004#line-10","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1050.0,"shares_display":"1,050","price_per_share":2.16,"price_display":"2.16","price_state":"stated","total_value":2268.0,"total_display":"2,268.00","shares_owned_after":66250.0,"shares_owned_after_display":"66,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-02-02","filed_date":"2009-02-04","scope":"insider"},{"id":5938572,"accession":"0001061983-09-000004","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001061983-09-000004","line_url":"/filing/0001061983-09-000004#line-9","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":950.0,"shares_display":"950","price_per_share":2.17,"price_display":"2.17","price_state":"stated","total_value":2061.5,"total_display":"2,061.50","shares_owned_after":65000.0,"shares_owned_after_display":"65,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-02-02","filed_date":"2009-02-04","scope":"insider"},{"id":5938570,"accession":"0001061983-09-000004","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001061983-09-000004","line_url":"/filing/0001061983-09-000004#line-8","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":2.19,"price_display":"2.19","price_state":"stated","total_value":1095.0,"total_display":"1,095.00","shares_owned_after":64500.0,"shares_owned_after_display":"64,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-02-02","filed_date":"2009-02-04","scope":"insider"},{"id":5938568,"accession":"0001061983-09-000004","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001061983-09-000004","line_url":"/filing/0001061983-09-000004#line-7","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":2.15,"price_display":"2.15","price_state":"stated","total_value":1075.0,"total_display":"1,075.00","shares_owned_after":67600.0,"shares_owned_after_display":"67,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-02-02","filed_date":"2009-02-04","scope":"insider"},{"id":5938566,"accession":"0001061983-09-000004","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001061983-09-000004","line_url":"/filing/0001061983-09-000004#line-6","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":2.13,"price_display":"2.13","price_state":"stated","total_value":1065.0,"total_display":"1,065.00","shares_owned_after":68100.0,"shares_owned_after_display":"68,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-02-02","filed_date":"2009-02-04","scope":"insider"},{"id":5938564,"accession":"0001061983-09-000004","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001061983-09-000004","line_url":"/filing/0001061983-09-000004#line-5","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":2.1099,"price_display":"2.11","price_state":"stated","total_value":843.96,"total_display":"843.96","shares_owned_after":68600.0,"shares_owned_after_display":"68,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-02-02","filed_date":"2009-02-04","scope":"insider"},{"id":5938563,"accession":"0001061983-09-000004","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001061983-09-000004","line_url":"/filing/0001061983-09-000004#line-4","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":2.1067,"price_display":"2.11","price_state":"stated","total_value":842.68,"total_display":"842.68","shares_owned_after":69000.0,"shares_owned_after_display":"69,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-02-02","filed_date":"2009-02-04","scope":"insider"},{"id":5938561,"accession":"0001061983-09-000004","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001061983-09-000004","line_url":"/filing/0001061983-09-000004#line-3","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":2.1633,"price_display":"2.16","price_state":"stated","total_value":648.99,"total_display":"648.99","shares_owned_after":65950.0,"shares_owned_after_display":"65,950","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-02-02","filed_date":"2009-02-04","scope":"insider"},{"id":5938559,"accession":"0001061983-09-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001061983-09-000004","line_url":"/filing/0001061983-09-000004#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":2.1522,"price_display":"2.15","price_state":"stated","total_value":645.66,"total_display":"645.66","shares_owned_after":67300.0,"shares_owned_after_display":"67,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-02-02","filed_date":"2009-02-04","scope":"insider"},{"id":5938558,"accession":"0001061983-09-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001061983-09-000004","line_url":"/filing/0001061983-09-000004#line-1","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":2.07,"price_display":"2.07","price_state":"stated","total_value":207.0,"total_display":"207.00","shares_owned_after":69400.0,"shares_owned_after_display":"69,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-02-02","filed_date":"2009-02-04","scope":"insider"},{"id":5696610,"accession":"0001061983-09-000001","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001061983-09-000001","line_url":"/filing/0001061983-09-000001#line-11","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1125.0,"shares_display":"1,125","price_per_share":2.89,"price_display":"2.89","price_state":"stated","total_value":3251.25,"total_display":"3,251.25","shares_owned_after":69500.0,"shares_owned_after_display":"69,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-01-02","filed_date":"2009-01-05","scope":"insider"},{"id":5696609,"accession":"0001061983-09-000001","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001061983-09-000001","line_url":"/filing/0001061983-09-000001#line-10","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":2.87,"price_display":"2.87","price_state":"stated","total_value":2583.0,"total_display":"2,583.00","shares_owned_after":71472.0,"shares_owned_after_display":"71,472","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-01-02","filed_date":"2009-01-05","scope":"insider"},{"id":5696608,"accession":"0001061983-09-000001","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001061983-09-000001","line_url":"/filing/0001061983-09-000001#line-9","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":847.0,"shares_display":"847","price_per_share":2.88,"price_display":"2.88","price_state":"stated","total_value":2439.36,"total_display":"2,439.36","shares_owned_after":70625.0,"shares_owned_after_display":"70,625","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-01-02","filed_date":"2009-01-05","scope":"insider"},{"id":5696607,"accession":"0001061983-09-000001","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001061983-09-000001","line_url":"/filing/0001061983-09-000001#line-8","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":2.85,"price_display":"2.85","price_state":"stated","total_value":1140.0,"total_display":"1,140.00","shares_owned_after":72372.0,"shares_owned_after_display":"72,372","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-01-02","filed_date":"2009-01-05","scope":"insider"},{"id":5696606,"accession":"0001061983-09-000001","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001061983-09-000001","line_url":"/filing/0001061983-09-000001#line-7","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":2.71,"price_display":"2.71","price_state":"stated","total_value":1084.0,"total_display":"1,084.00","shares_owned_after":74100.0,"shares_owned_after_display":"74,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-01-02","filed_date":"2009-01-05","scope":"insider"},{"id":5696605,"accession":"0001061983-09-000001","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001061983-09-000001","line_url":"/filing/0001061983-09-000001#line-6","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":312.0,"shares_display":"312","price_per_share":2.75,"price_display":"2.75","price_state":"stated","total_value":858.0,"total_display":"858.00","shares_owned_after":73788.0,"shares_owned_after_display":"73,788","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-01-02","filed_date":"2009-01-05","scope":"insider"},{"id":5696604,"accession":"0001061983-09-000001","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001061983-09-000001","line_url":"/filing/0001061983-09-000001#line-5","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":2.8,"price_display":"2.80","price_state":"stated","total_value":840.0,"total_display":"840.00","shares_owned_after":72972.0,"shares_owned_after_display":"72,972","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-01-02","filed_date":"2009-01-05","scope":"insider"},{"id":5696603,"accession":"0001061983-09-000001","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001061983-09-000001","line_url":"/filing/0001061983-09-000001#line-4","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":288.0,"shares_display":"288","price_per_share":2.76,"price_display":"2.76","price_state":"stated","total_value":794.88,"total_display":"794.88","shares_owned_after":73500.0,"shares_owned_after_display":"73,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-01-02","filed_date":"2009-01-05","scope":"insider"},{"id":5696602,"accession":"0001061983-09-000001","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001061983-09-000001","line_url":"/filing/0001061983-09-000001#line-3","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":2.81,"price_display":"2.81","price_state":"stated","total_value":562.0,"total_display":"562.00","shares_owned_after":72772.0,"shares_owned_after_display":"72,772","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-01-02","filed_date":"2009-01-05","scope":"insider"},{"id":5696601,"accession":"0001061983-09-000001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001061983-09-000001","line_url":"/filing/0001061983-09-000001#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":128.0,"shares_display":"128","price_per_share":2.79,"price_display":"2.79","price_state":"stated","total_value":357.12,"total_display":"357.12","shares_owned_after":73272.0,"shares_owned_after_display":"73,272","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-01-02","filed_date":"2009-01-05","scope":"insider"},{"id":5696600,"accession":"0001061983-09-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001061983-09-000001","line_url":"/filing/0001061983-09-000001#line-1","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":2.78,"price_display":"2.78","price_state":"stated","total_value":278.0,"total_display":"278.00","shares_owned_after":73400.0,"shares_owned_after_display":"73,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-01-02","filed_date":"2009-01-05","scope":"insider"},{"id":3345988,"accession":"0001061983-08-000034","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001061983-08-000034","line_url":"/filing/0001061983-08-000034#line-11","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1380.0,"shares_display":"1,380","price_per_share":2.08,"price_display":"2.08","price_state":"stated","total_value":2870.4,"total_display":"2,870.40","shares_owned_after":78120.0,"shares_owned_after_display":"78,120","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-12-01","filed_date":"2008-12-02","scope":"insider"},{"id":3345984,"accession":"0001061983-08-000034","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001061983-08-000034","line_url":"/filing/0001061983-08-000034#line-10","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1165.0,"shares_display":"1,165","price_per_share":2.1,"price_display":"2.10","price_state":"stated","total_value":2446.5,"total_display":"2,446.50","shares_owned_after":76800.0,"shares_owned_after_display":"76,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-12-01","filed_date":"2008-12-02","scope":"insider"},{"id":3345981,"accession":"0001061983-08-000034","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001061983-08-000034","line_url":"/filing/0001061983-08-000034#line-9","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":2.22,"price_display":"2.22","price_state":"stated","total_value":1554.0,"total_display":"1,554.00","shares_owned_after":75460.0,"shares_owned_after_display":"75,460","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-12-01","filed_date":"2008-12-02","scope":"insider"},{"id":3345979,"accession":"0001061983-08-000034","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001061983-08-000034","line_url":"/filing/0001061983-08-000034#line-8","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":460.0,"shares_display":"460","price_per_share":2.24,"price_display":"2.24","price_state":"stated","total_value":1030.4,"total_display":"1,030.40","shares_owned_after":75000.0,"shares_owned_after_display":"75,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-12-01","filed_date":"2008-12-02","scope":"insider"},{"id":3345976,"accession":"0001061983-08-000034","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001061983-08-000034","line_url":"/filing/0001061983-08-000034#line-7","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":429.0,"shares_display":"429","price_per_share":2.14,"price_display":"2.14","price_state":"stated","total_value":918.06,"total_display":"918.06","shares_owned_after":76160.0,"shares_owned_after_display":"76,160","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-12-01","filed_date":"2008-12-02","scope":"insider"},{"id":3345973,"accession":"0001061983-08-000034","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001061983-08-000034","line_url":"/filing/0001061983-08-000034#line-6","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001288528","owner_name":"MORGANS DAVID J JR","owner_url":"/insider/0001288528","role":"Officer (EVP-Preclinical R&D)","officer_title":"EVP-Preclinical R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":211.0,"shares_display":"211","price_per_share":2.12,"price_display":"2.12","price_state":"stated","total_value":447.32,"total_display":"447.32","shares_owned_after":76589.0,"shares_owned_after_display":"76,589","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-12-01","filed_date":"2008-12-02","scope":"insider"}],"next_cursor":"2008-12-01|3345973","ledger_fault":false,"count":{"value":110,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":110,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":110},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001061983","name":"CYTOKINETICS INC","url":"/issuer/0001061983","role":"Officer (EVP-Preclinical R&D)","n_filings":27,"first_seen":"2005-11-04","last_seen":"2009-10-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001288528","retrieved_at":"2026-08-21T03:27:44+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}